Skip to main content
Premium Trial:

Request an Annual Quote

CollabRx Inks Distribution Deal with Projects In Knowledge

NEW YORK (GenomeWeb News) – CollabRx announced this week that it has signed an agreement with Projects In Knowledge to jointly distribute informational point-of-care software applications to oncologists and clinicians in the Projects In Knowledge clinician network.

Projects In Knowledge is a developer of point-of-care digital and mobile information tools and continuing medical education programs and said that it has more than 35,000 oncologists and clinicians in its network.

The alliance will integrate CollabRx's Therapy Finder products into the Projects In Knowledge Point of Care360 platform. Therapy Finder provides decision support tools that enable oncologists and pathologists to take into account the genetics of a patient's tumor when determining a treatment plan, said San Francisco-based CollabRx.

"This agreement represents a significant milestone by CollabRx in facilitating access to its Therapy Finder product line by large numbers of practicing physicians to inform cancer treatment planning at the point of care," CollabRx President and CEO Thomas Mika said in a statement.

Further terms of the agreement were not disclosed.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.